Rankings for Scientist

University, Subject, Country, Region, World

GlaxoSmithKline Scientist Rankings 2023

AD Scientific Index analyzes academic studies from 1 countries, 1 universities/institutions, and 403 scientists by using numerous criteria to present results to be used for the evaluation of productivity and efficiency by individuals and institutions. In addition to sorting by the “total H-index” you can find here, you can examine several rankings and analyses by the "last 6 years H-index", "total i10 index", "last 6 years' i10 index", "total number of citations", and “last 6 years’ citations”. Please read the methodology section for “Limitations and Possible Reasons Why a Scientist Is Not on This List”. Click for individual or institutional registration.

map
Total 403 scientist, 1 country, 1 university
AD Scientific Index - World Scientist Rankings - 2023 H INDEX i10 INDEX CITATION
University / Institution Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
1 88 432 1159
Rino RappuoliRino Rappuoli
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Vaccines | infectious diseases | vaccinology | global health |

152 76 0.500 720 402 0.558 89671 23210 0.259
2 142 604 1692
Paul Peter TakPaul Peter Tak
United Kingdom GlaxoSmithKline GlaxoSmithKline Candel Therapeutics, GlaxoSmithKline, Kintai Therapeutics, Academic Medical Center, Amsterdam

immunology | oncology | rheumatology | internal medicine |

138 71 0.514 564 405 0.718 83187 29744 0.358
3 490 1829 5531
Peter HowarthPeter Howarth
United Kingdom GlaxoSmithKline GlaxoSmithKline SOUTHAMPTON and GSK

104 52 0.500 328 193 0.588 47590 11516 0.242
4 621 2261 6884
Derek O'HaganDerek O'Hagan
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Vaccines | adjuvants | RNA vaccines | LNP |

99 46 0.465 287 162 0.564 28636 7749 0.271
5 1048 3799 11579
Jaegil KimJaegil Kim
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Cancer Genomics |

85 81 0.953 129 104 0.806 75881 62502 0.824
6 1078 3909 11923
Caroline SavageCaroline Savage
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Immunology

immunology | renal medicine |

85 36 0.424 222 102 0.459 27478 6506 0.237
7 1280 4673 14230
Mariagrazia PizzaMariagrazia Pizza
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Vaccines | pathogenesis |

81 40 0.494 257 152 0.591 24496 6198 0.253
8 1416 5151 15707
Allan SaulAllan Saul
United Kingdom GlaxoSmithKline GlaxoSmithKline Director of GSK Vaccines Institute for Global Health

Vaccines | public health |

79 35 0.443 276 120 0.435 20844 4600 0.221
9 1492 5436 16536
Toby JohnsonToby Johnson i
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

77 56 0.727 119 97 0.815 51038 18723 0.367
10 2509 9326 27842
Rab PrinjhaRab Prinjha
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithkline

Epigenetics | Immunology |

66 51 0.773 125 117 0.936 19222 9514 0.495

The most comprehensive analysis and comparisons about your institution
11 2997 11283 33245
David ToughDavid Tough
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Immunology

Immunology | Epigenetics |

62 34 0.548 99 66 0.667 20293 4366 0.215
12 3045 11517 33876
Neil BarnesNeil Barnes
United Kingdom GlaxoSmithKline GlaxoSmithKline Professor

Respiratory disease |

62 32 0.516 98 56 0.571 14530 4044 0.278
13 3135 11914 34967
Jerry L AdamsJerry L Adams
United Kingdom GlaxoSmithKline GlaxoSmithKline Research Director for GlaxoSmithKline

drug discovery |

61 25 0.410 130 47 0.362 18505 2410 0.130
14 3426 13080 38414
Gerard DrewesGerard Drewes
United Kingdom GlaxoSmithKline GlaxoSmithKline Cellzome/GlaxoSmithKline R&D

Drug Discovery | Chemical Biology | Proteomics | Kinases |

59 41 0.695 102 82 0.804 28646 8576 0.299
15 3443 13142 38603
Marcus BantscheffMarcus Bantscheff
United Kingdom GlaxoSmithKline GlaxoSmithKline Cellzome, a GSK company

Proteomics | Chemical Biologý |

59 48 0.814 102 83 0.814 20012 10912 0.545
16 3581 13782 40427
Sanjay KumarSanjay Kumar
United Kingdom GlaxoSmithKline GlaxoSmithKline glaxosmithkline

58 30 0.517 168 97 0.577 22427 4515 0.201
17 3613 13864 40670
Philippe BuchyPhilippe Buchy
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines R&D

virology - vaccinology |

58 39 0.672 177 135 0.763 17054 9228 0.541
18 3980 15387 44966
Christine PowerChristine Power
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Therapeutic antibody discovery and development |

56 24 0.429 89 44 0.494 16275 2197 0.135
19 4505 17892 52040
Millard H LambertMillard H Lambert
United Kingdom GlaxoSmithKline GlaxoSmithKline Computational Chemist, GlaxoSmithKline

Drug Discovery | Drug Design |

53 32 0.604 78 46 0.590 24455 3669 0.150
20 5372 21571 62194
David J PayneDavid J Payne
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline, Univeristy of Edinburgh, University Brunel

50 22 0.440 74 35 0.473 9992 2599 0.260
21 5412 21762 62711
Timothy M ClayTimothy M Clay
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Cancer | infectious disease | vaccines | cell and gene therapy |

50 26 0.520 104 51 0.490 9057 2448 0.270
22 5791 23627 67766
Roland S. AnnanRoland S. Annan
United Kingdom GlaxoSmithKline GlaxoSmithKline

Mass Spectrometry | Proteomics | Phosphorylation |

48 22 0.458 69 38 0.551 15521 3081 0.199
23 5869 23905 68622
Amanda LeachAmanda Leach
United Kingdom GlaxoSmithKline GlaxoSmithKline

Vaccine Malaria |

48 23 0.479 66 43 0.652 10215 2283 0.223
24 6394 26576 75806
John R WhiteJohn R White
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Chemokines | Cytokines | Immunology | receptors | potency assays |

46 16 0.348 75 22 0.293 11437 994 0.087
25 6689 28114 79959
Colin MacpheeColin Macphee
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacology

Pharmacolgy |

45 21 0.467 82 40 0.488 11033 1532 0.139
26 6694 28134 80011
Roger A LevyRoger A Levy
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Lupus | rheumatology | pregnancy | antiphospholipid syndrome | Sjogren's syndrome |

45 30 0.667 113 71 0.628 10834 4632 0.428
27 6697 28138 80048
Vinod KumarVinod Kumar
United Kingdom GlaxoSmithKline GlaxoSmithKline Sr. Investigator, GlaxoSmithKline Pharmaceuticals

Bioinformatics | Text mining | Compuattional Biology | Drug Repositioning |

45 32 0.711 217 104 0.479 10608 5179 0.488
28 7108 30083 85176
Eduardo Ortega-BarriaEduardo Ortega-Barria
United Kingdom GlaxoSmithKline GlaxoSmithKline VP & Head, Clinical R&D and Medical Affairs Latin America and the Caribbean

Vaccines | Infectious Disease | Pediatrics | Tropical Medicine & Parasitolgy |

44 24 0.545 92 51 0.554 8593 2006 0.233
29 7331 31350 88464
Alistair RustAlistair Rust
United Kingdom GlaxoSmithKline GlaxoSmithKline Computational Biologist, GSK

Bioinformatics | Cancer Genetics | Big Data | HPC | Drug Discovery |

43 31 0.721 67 46 0.687 21988 5990 0.272
30 7350 31423 88718
Frank StruyfFrank Struyf
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

43 34 0.791 69 59 0.855 13866 7776 0.561
31 7845 33849 95310
Sylvie BertholetSylvie Bertholet
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Immunology

immunology | vaccine | host-pathogen interaction |

42 26 0.619 65 52 0.800 7585 2741 0.361
32 8104 35320 99194
George P LiviGeorge P Livi
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

Molecular Biology | Genetics | Genomics | Transcriptomics | Yeast |

41 18 0.439 77 26 0.338 11882 1271 0.107
33 8229 35738 100352
Andrew BateAndrew Bate
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacovigilance | Pharmacoepidemiology | Data Mining | Clinical Pharmacology | Drug Safety |

41 28 0.683 70 55 0.786 7809 3249 0.416
34 8269 35935 100954
Javier GamoJavier Gamo
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Infectious diseases. Parasitology. Drug Discovery.Molecular Biology. Biochemistry. Genetics. Malaria |

41 31 0.756 79 66 0.835 7124 3807 0.534
35 8479 37003 103713
Iain A GillespieIain A Gillespie
United Kingdom GlaxoSmithKline GlaxoSmithKline Real-World Evidence & Epidemiology, GSK

Epidemiology |

41 21 0.512 63 37 0.587 5187 1326 0.256
36 8521 37333 104545
Erding HuErding Hu
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline Pharmaceuticals

Drug discovery | Cell biology | Renal and cardiovascular disease |

40 25 0.625 48 36 0.750 20050 2848 0.142
37 8537 37390 104726
Kurt AugerKurt Auger
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Cancer cell biology | Tumor cell signaling | Synthetic Lethality |

40 22 0.550 53 30 0.566 13704 1967 0.144
38 8957 39524 110557
Shanker Kalyana-SundaramShanker Kalyana-Sundaram
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline, Collegeville

Bioinformatics | Cancer Biology | Big Data | Cloud Computing |

39 31 0.795 47 42 0.894 21636 8040 0.372
39 9414 41916 117009
Erik ArnerErik Arner i
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

bioinformatics | epigenomics | transcriptomics | adipogenesis | obesity |

38 30 0.789 61 53 0.869 15858 8253 0.520
40 9517 42379 118473
Maciej Zamek-GliszczynskiMaciej Zamek-Gliszczynski
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacokinetics | Clinical Pharmacology | Drug Development |

38 24 0.632 55 44 0.800 7050 2941 0.417

 New. 2023 Country Top Lists: Top 10000, 5000, 3000, 2000, 1000. Only in AD Scientific Index
41 9537 42463 118731
María S. MartínezMaría S. Martínez
United Kingdom GlaxoSmithKline GlaxoSmithKline Investigator, GSK

DMPK |

38 28 0.737 104 65 0.625 6721 3007 0.447
42 9577 42664 119280
Dennis A HoltDennis A Holt
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Drug Discovery |

38 18 0.474 88 32 0.364 6256 1178 0.188
43 9642 42986 120158
Nathalie NoraisNathalie Norais
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Vaccines | Structural Mass Spectrometry | Proteomics |

38 25 0.658 64 44 0.688 5677 1763 0.311
44 9850 44326 123538
Roberto AdamoRoberto Adamo
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

38 27 0.711 67 56 0.836 3630 2197 0.605
45 9863 44394 123732
Dean E McnultyDean E Mcnulty
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

37 20 0.541 47 29 0.617 16717 2724 0.163
46 9925 44622 124432
Michael T. MccabeMichael T. Mccabe
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

Epigenetics | Oncology |

37 27 0.730 44 38 0.864 8449 4529 0.536
47 9968 44785 124892
Sabyasachi BhattacharyaSabyasachi Bhattacharya
United Kingdom GlaxoSmithKline GlaxoSmithKline Investigator, GlaxoSmithKline

Onco immunology |

37 24 0.649 82 45 0.549 7390 3159 0.427
48 10120 45445 126699
Nicholas GalweyNicholas Galwey
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Biostatistics

biostatistics |

37 21 0.568 69 42 0.609 5667 1735 0.306
49 10416 47237 131394
Andreas CrameriAndreas Crameri
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

BioTech | Molecular Biology Protein evolution |

36 25 0.694 51 41 0.804 11775 2850 0.242
50 10537 47765 133012
Domenico MaioneDomenico Maione
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Biological Science

Biologia | Microbiologia | Biochimica |

36 23 0.639 56 40 0.714 6336 1901 0.300
51 10558 47887 133378
Pierre WattiauPierre Wattiau
United Kingdom GlaxoSmithKline GlaxoSmithKline Sr Scientist, GSK Vaccines

Molecular Microbiology |

36 21 0.583 60 38 0.633 5994 1406 0.235
52 10670 48396 134726
Alessandro MuzziAlessandro Muzzi
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Biological Science

Systems Biology | Transcriptomics | Gene Expression | Genomics | Bioinformatics |

36 21 0.583 49 36 0.735 5156 1597 0.310
53 11108 50872 141338
Lisa ShewchukLisa Shewchuk
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithkline

structure biology |

35 18 0.514 53 30 0.566 5711 1383 0.242
54 11403 52364 145233
Anthony M LynchAnthony M Lynch
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

genetic toxicology | photo-safety | mutagens | carcinogens | non-clinical safety |

35 18 0.514 66 26 0.394 4087 958 0.234
55 11606 53625 148623
Mike HannMike Hann
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Medicinal chemistry | Fragments | chemical biology | drug discovery |

34 23 0.676 51 28 0.549 7142 2328 0.326

January 1, 2022 Total 716.979 scientist, 212 country, 14.130 university... January 6, 2023 Total 1.264.669 scientist, 216 country, 19.528 university
56 12159 56688 156775
Margaret (Meg) Gelder EhmMargaret (Meg) Gelder Ehm
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

statistics | genetics |

33 17 0.515 44 25 0.568 11937 2280 0.191
57 12255 57023 157810
Sandra NutiSandra Nuti
United Kingdom GlaxoSmithKline GlaxoSmithKline Head of FACS Facility, Preclinical R&D, GSK Vaccines, Rockville, MD

flow cytometry | immunology | vaccines |

33 17 0.515 53 28 0.528 6577 1247 0.190
58 12264 57077 157975
Diana L CousminerDiana L Cousminer
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

genetics |

33 29 0.879 46 45 0.978 6305 4125 0.654
59 13569 64275 177320
Robert T. NolteRobert T. Nolte
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Protein Crystallography |

31 24 0.774 35 31 0.886 8688 1582 0.182
60 13618 64407 177768
Robert MarquisRobert Marquis
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

31 19 0.613 54 33 0.611 6866 3244 0.472
61 13727 64867 179074
Ganesh SatheGanesh Sathe
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

DNA Sequencing |

31 17 0.548 54 22 0.407 5065 1077 0.213
62 13731 64913 179182
Laure RittiéLaure Rittié
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

Gene Therapy | Immuno-Oncology | Dermatology | Tissue repair |

31 23 0.742 42 33 0.786 4974 2417 0.486
63 14072 66609 183671
Luis A. Vale-SilvaLuis A. Vale-Silva
United Kingdom GlaxoSmithKline GlaxoSmithKline Cellzome, a GSK company

Spatial Omics | Multiomics | Cancer | Computer Vision | Deep Learning |

31 24 0.774 46 30 0.652 3482 1794 0.515
64 14318 68344 188107
Pichai RamanPichai Raman
United Kingdom GlaxoSmithKline GlaxoSmithKline Engineering & Technology / Computer Science

Data Mining | Cancer Biology | Early Target Discovery |

30 29 0.967 43 41 0.953 14577 10271 0.705
65 14334 68400 188271
Andrew W NichollsAndrew W Nicholls
United Kingdom GlaxoSmithKline GlaxoSmithKline Head of Bioimaging, GlaxoSmithKline

metabolomics | toxicology | imaging |

30 16 0.533 48 23 0.479 10498 4936 0.470
66 14375 68611 188928
Kendall FrazierKendall Frazier
United Kingdom GlaxoSmithKline GlaxoSmithKline glaxosmithkline

Toxicology | Pathology |

30 20 0.667 60 33 0.550 6469 2068 0.320
67 14377 68615 188944
Jing ChenJing Chen
United Kingdom GlaxoSmithKline GlaxoSmithKline Cincinnati Children's Hospital Medical Center

Bioinformatics | Computational biology | Genetic disease | Drug Discovery |

30 23 0.767 44 34 0.773 6437 3669 0.570
68 14494 69163 190646
Kristin (Koretke) BrownKristin (Koretke) Brown
United Kingdom GlaxoSmithKline GlaxoSmithKline Agenus

computational biology/chemistry | target tractability | antibody design | directed evolution | protein engineering |

30 18 0.600 36 24 0.667 4605 1246 0.271
69 14538 69379 191263
Kevin J DuffyKevin J Duffy
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

30 15 0.500 54 20 0.370 4298 1540 0.358
70 14620 69804 192368
Shari N GordonShari N Gordon
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline and the UNC HIV Cure Center

HIV |

30 18 0.600 40 29 0.725 3901 1027 0.263
71 15058 72717 200094
Philippe SanseauPhilippe Sanseau
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

29 19 0.655 42 24 0.571 12068 5163 0.428
72 15072 72770 200287
Jimmy Zhenli LiuJimmy Zhenli Liu i
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Statistical genetics | genetic epidemiology | genetics | bioinformatics |

29 25 0.862 36 32 0.889 8987 5895 0.656
73 15080 72795 200379
Laura A JohnsonLaura A Johnson
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

cancer | immunotherapy | cell therapy | gene therapy | GBM |

29 26 0.897 34 32 0.941 8186 4466 0.546
74 15141 73021 201079
Puneet DhawanPuneet Dhawan
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

Genomics | NGS | Vitamin D |

29 20 0.690 35 29 0.829 5796 2910 0.502
75 15232 73406 202252
Ian ChurcherIan Churcher
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

drug discovery |

29 18 0.621 47 28 0.596 4557 2837 0.623
76 15241 73469 202431
Sharon SweitzerSharon Sweitzer
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

29 15 0.517 32 19 0.594 4445 1191 0.268
77 16135 78447 216003
Esther Perez-HerránEsther Perez-Herrán
United Kingdom GlaxoSmithKline GlaxoSmithKline Investigator

microbiology |

28 22 0.786 41 33 0.805 3939 1425 0.362
78 16313 79246 218168
James YatesJames Yates
United Kingdom GlaxoSmithKline GlaxoSmithKline Scientific Director, GSK

Drug discovery | pharmacology | mathematical modelling |

28 21 0.750 55 43 0.782 3310 2175 0.657
79 16468 80155 220478
William FeeneyWilliam Feeney
United Kingdom GlaxoSmithKline GlaxoSmithKline

oncology | immunology | animal models |

28 9 0.321 36 6 0.167 2926 346 0.118
80 16583 81031 222708
Christian FufezanChristian Fufezan
United Kingdom GlaxoSmithKline GlaxoSmithKline Group Leader Computational Mass Spectrometry Cellzome - GSK

Data engineering | Computational Biology | ROS | Proteostasis |

28 21 0.750 39 33 0.846 2636 1350 0.512
81 16680 81789 224701
Robert J WatsonRobert J Watson
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

medicinal chemistry |

28 17 0.607 56 31 0.554 2372 940 0.396
82 16774 82623 226884
Pankaj AgarwalPankaj Agarwal
United Kingdom GlaxoSmithKline GlaxoSmithKline Chief Computational Biologist, BioInfi

Computational Biology | Bioinformatics | Drug Discovery | Target Prioritization | Drug Repositioning |

27 20 0.741 48 31 0.646 12215 2697 0.221
83 16825 82808 227518
Euan StronachEuan Stronach
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Medical Oncology

Oncology | Functional Genomics |

27 23 0.852 37 32 0.865 6421 4223 0.658
84 17066 83826 230494
Augustin AmourAugustin Amour
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

PI3K | Kinases | Proteases | metalloproteinases |

27 14 0.519 38 22 0.579 3636 803 0.221
85 17248 84767 233032
Stephen CastellinoStephen Castellino
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Chemical Sciences

chemistry | drug metabolism | spectrscopy | NMR | MALDI |

27 17 0.630 41 22 0.537 3054 990 0.324
86 17282 84934 233530
Neil D PearsonNeil D Pearson
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Medicinal Chemistry and Infectious Disease |

27 11 0.407 54 13 0.241 2972 966 0.325
87 17438 86064 236535
Richard LonsdaleRichard Lonsdale
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Computational Chemistry |

27 23 0.852 35 35 1.000 2579 1557 0.604
88 17597 87331 239840
Gerben BoumaGerben Bouma
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Immunology

Immunology |

27 16 0.593 33 21 0.636 2193 727 0.332
89 17694 88122 241959
Gregg FineGregg Fine
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

Immunotherapy | Cell therapy | Urothelial carcinoma | Renal cell carcinoma | PD-L1 |

26 17 0.654 33 21 0.636 18197 12987 0.714
90 17716 88198 242202
Adrián CortésAdrián Cortés
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

statistical genetics | genetics of immune-mediated diseases |

26 25 0.962 33 32 0.970 9202 7519 0.817

Institutional Subscription (Discount and Free Institutional Academic Performance Report)
91 17831 88696 243838
John D LichJohn D Lich
United Kingdom GlaxoSmithKline GlaxoSmithKline Pharma

Immuno-inflammation |

26 19 0.731 28 22 0.786 4339 1875 0.432
92 17981 89386 245733
James ButlerJames Butler
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline, GSK

biopharmaceutics | dissolution | drug delivery |

26 23 0.885 36 31 0.861 3419 1737 0.508
93 18114 90100 247683
Lisa MarcaurelleLisa Marcaurelle
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

26 14 0.538 41 19 0.463 2990 618 0.207
94 18123 90144 247786
Leonardo GiovannoniLeonardo Giovannoni
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

clinical research |

26 19 0.731 31 23 0.742 2972 935 0.315
95 18519 92987 255296
Gossett CampbellGossett Campbell
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline Inc

26 11 0.423 33 11 0.333 2118 302 0.143
96 18797 94794 260388
Richard M. DunhamRichard M. Dunham
United Kingdom GlaxoSmithKline GlaxoSmithKline Director, HIV Cure- ViiV Healthcare; Adj Asst Prof, UNC

HIV Cure | HIV Immunopathogenesis | Mucosal Immunology | Drug Discovery |

25 17 0.680 30 25 0.833 4073 1490 0.366
97 18907 95372 262070
Roberto RosiniRoberto Rosini
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

Vaccines | Molecular biology | Genomics |

25 20 0.800 30 26 0.867 3280 1203 0.367
98 19162 96658 265568
Christopher Arico-MuendelChristopher Arico-Muendel
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

medicinal chemistry | drug discovery |

25 14 0.560 35 21 0.600 2604 932 0.358
99 19474 98744 271098
Jeremy Thomas O'BrienJeremy Thomas O'Brien
United Kingdom GlaxoSmithKline GlaxoSmithKline Development Scientist at GSK

Chemistry | Mass Spectrometry | Infrared Spectroscopy |

25 16 0.640 34 25 0.735 2092 651 0.311
100 19542 99271 272413
David A HallDavid A Hall
United Kingdom GlaxoSmithKline GlaxoSmithKline Medical and Health Sciences / Pharmacology

Pharmacology | Receptor Theory | GPCRs | Allosteric modulation |

25 13 0.520 37 17 0.459 1985 425 0.214